Protara Therapeutics Ownership | Who Owns Protara Therapeutics?

Protara Therapeutics Ownership Summary

Protara Therapeutics is owned by 9.29% institutional investors, 3.68% insiders, and 87.03% retail investors. Ra capital management is the largest institutional shareholder, holding 15.23% of TARA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.78% of its assets in Protara Therapeutics shares.

TARA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Protara Therapeutics	9.29%	3.68%	87.03%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	3.40M	15.23%	$17.95M
Janus henderson group	2.27M	10.17%	$11.94M
Adage capital partners gp	2.25M	10.08%	$11.88M
Toronto dominion bank	2.09M	9.35%	$11.03M
Opaleye management	1.82M	8.17%	$9.64M
Blackstone	1.68M	7.52%	$8.87M
Boxer capital	811.63K	7.11%	$1.69M
Velan capital investment management lp	1.58M	7.07%	$8.34M
Sio capital management	1.44M	6.44%	$7.59M
Integral health asset management	1.40M	6.27%	$7.39M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Velan capital investment management lp	1.58M	7.19%	$8.34M
Sio capital management	1.44M	2.14%	$7.59M
Opaleye management	1.82M	1.69%	$9.64M
Superstring capital management lp	360.00K	1.65%	$1.90M
5am venture management	800.00K	1.01%	$4.22M
Integral health asset management	1.40M	0.63%	$7.39M
Cvi	302.75K	0.54%	$629.71K
Stempoint capital lp	332.39K	0.44%	$1.76M
Ikarian capital	350.49K	0.25%	$1.85M
Ra capital management	3.40M	0.24%	$17.95M

Top Buyers

Holder	Shares	% Assets	Change
Janus henderson group	2.27M	0.01%	2.27M
Adage capital partners gp	2.25M	0.02%	2.25M
Toronto dominion bank	2.09M	0.02%	2.09M
Blackstone	1.68M	0.04%	1.68M
Ra capital management	3.40M	0.24%	1.50M

Top Sellers

Holder	Shares	% Assets	Change
Stempoint capital lp	332.39K	0.44%	-610.46K
Armistice capital	-	-	-520.00K
Renaissance	142.30K	0.00%	-194.44K
Two sigma investments, lp	13.63K	0.00%	-171.59K
Two sigma advisers, lp	-	-	-151.62K

New Positions

Holder	Shares	% Assets	Change	Value
Janus henderson group	2.27M	0.01%	2.27M	$11.94M
Adage capital partners gp	2.25M	0.02%	2.25M	$11.88M
Toronto dominion bank	2.09M	0.02%	2.09M	$11.03M
Blackstone	1.68M	0.04%	1.68M	$8.87M
Sio capital management	1.44M	2.14%	1.44M	$7.59M

Sold Out

Holder	Change
Qube research	-2.00
Jpmorgan chase	-22.00
Advisor group	-100.00
Acadian asset management	-6.31K
Wolverine trading	-10.70K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	12	-66.67%	2,074,529	-80.14%	9	0.42%	8	-55.56%	3	-57.14%
Sep 30, 2024	36	-14.29%	10,447,278	-0.02%	46	0.56%	18	-28.00%	7	-12.50%
Jun 30, 2024	42	7.69%	10,449,817	128.63%	91	5.62%	25	56.25%	8	-11.11%
Mar 31, 2024	39	21.88%	4,570,660	4.88%	40	2.73%	16	77.78%	9	50.00%
Dec 31, 2023	32	-	4,358,148	-14.85%	38	1.87%	9	28.57%	6	-33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.02M	2.78%	-
Vanguard US Total Market Shares ETF	616.30K	1.74%	-
Vanguard Institutional Extnd Mkt Idx Tr	296.00K	0.81%	-
A4Investments SICAV SIF ACCI IlanaA2EURH	125.00K	0.61%	-
BlackRock Extended Equity Market K	54.38K	0.26%	-23.00
Fidelity Extended Market Index	93.91K	0.26%	-598.00
Vifag 2002 SICAV	75.00K	0.20%	-
Extended Equity Market Fund K	53.80K	0.15%	165.00
iShares Micro-Cap ETF	40.95K	0.11%	-
NT Ext Equity Mkt Idx Fd - L	37.21K	0.10%	18.22K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 26, 2025	Zummo Jacqueline	Chf Scientific Operations Off	Sell	$96.14K
Sep 11, 2024	Opaleye Management Inc.	-	Sell	$2.74K
Sep 12, 2024	Opaleye Management Inc.	-	Sell	$11.11K
Sep 12, 2024	Opaleye Management Inc.	-	Sell	$204.73K
Sep 11, 2024	Opaleye Management Inc.	-	Sell	$53.14K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	1
2024 Q3	-	18
2024 Q2	-	18
2024 Q1	-	-
2023 Q3	-	-

TARA Ownership FAQ

Who Owns Protara Therapeutics?

Protara Therapeutics shareholders are primarily institutional investors at 9.29%, followed by 3.68% insiders and 87.03% retail investors. The average institutional ownership in Protara Therapeutics's industry, Biotech Stocks , is 68.48%, which Protara Therapeutics falls below.

Who owns the most shares of Protara Therapeutics?

Protara Therapeutics’s largest shareholders are Ra capital management (3.4M shares, 15.23%), Janus henderson group (2.27M shares, 10.17%), and Adage capital partners gp (2.25M shares, 10.08%). Together, they hold 35.48% of Protara Therapeutics’s total shares outstanding.

Does Blackrock own Protara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Protara Therapeutics.

Who is Protara Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Protara Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.19% of its assets in 1.58M Protara Therapeutics shares, valued at 8.34M$.

Who is the top mutual fund holder of Protara Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Protara Therapeutics shares, with 2.78% of its total shares outstanding invested in 1.02M Protara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools